Koen Debackere

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Why advanced therapy medicinal products struggle in clinical translation: an in-depth analysis of developmental challenges in the EU.

Why advanced therapy medicinal products struggle in clinical translation: an in-depth analysis of developmental challenges in the EU.

Journal: Frontiers in medicine
Published: March 26, 2026

Optical Genome Mapping Is a Powerful Diagnostic Tool in Non-Hodgkin Lymphoma.

Optical Genome Mapping Is a Powerful Diagnostic Tool in Non-Hodgkin Lymphoma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: July 10, 2025

Invasive Trichoderma longibrachiatum breakthrough infection in a hematology patient.

Invasive Trichoderma longibrachiatum breakthrough infection in a hematology patient.

Journal: Medical mycology case reports
Published: March 10, 2025

Xq24/IL13RA1 aberrations as key drivers of female bias in primary mediastinal large B-cell lymphoma.

Xq24/IL13RA1 aberrations as key drivers of female bias in primary mediastinal large B-cell lymphoma.

Journal: HemaSphere
Published: December 27, 2024

t(9;12)(q22;p13) ETV6::SYK: A new recurrent cytogenetic aberration and tyrosine kinase gene fusion in myeloid or lymphoid neoplasms associated with eosinophilia.

t(9;12)(q22;p13) ETV6::SYK: A new recurrent cytogenetic aberration and tyrosine kinase gene fusion in myeloid or lymphoid neoplasms associated with eosinophilia.

Journal: British journal of haematology
Published: June 20, 2022

Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma.

Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma.

Journal: Blood
Published: March 23, 2022

Primary mediastinal large B-cell lymphoma is characterized by large-scale copy-neutral loss of heterozygosity.

Primary mediastinal large B-cell lymphoma is characterized by large-scale copy-neutral loss of heterozygosity.

Journal: Genes, chromosomes & cancer
Published: January 10, 2022

Correction to: In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy.

Correction to: In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy.

Journal: Cancer immunology, immunotherapy : CII
Published: February 17, 2021

Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified.

Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified.

Journal: Nature communications
Published: February 03, 2021

In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy.

In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy.

Journal: Cancer immunology, immunotherapy : CII
Published: November 28, 2019

FER and FES tyrosine kinase fusions in follicular T-cell lymphoma.

FER and FES tyrosine kinase fusions in follicular T-cell lymphoma.

Journal: Blood
Published: November 21, 2019

Coexisting driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients.

Coexisting driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients.

Journal: Hematology (Amsterdam, Netherlands)
Published: July 12, 2018
Showing 1-12 of 14

Last Updated: 09/26/2026